NT
Healthcare & Life Sciences
Neusignal Therapeutics
Neusignal Therapeutics is a Healthcare & Life Sciences startup based in Japan, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Neusignal Therapeutics
Neusignal Therapeutics is a company headquartered in Japan. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Neusignal Therapeutics develops small molecule drugs targeting brain diseases, focusing on therapeutic agents for dementia, psychiatric disorders, and other central nervous system diseases.
Explore Neusignal Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.